-
Mashup Score: 0Simple Sitting-Rising Test Linked to Natural and CV Mortality - 6 hour(s) ago
The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI platforms.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms https://t.co/JdCrLTCF5c https://t.co/X96e9ykG26
-
-
Mashup Score: 0‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use - 9 hour(s) ago
Responding to MAUDE data, some have safety concerns but others aren’t surprised to see more events in higher-risk patients.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use https://t.co/onPzd7M63v https://t.co/cw90FVwQyy
-
-
Mashup Score: 6Registration - 10 hour(s) ago
Registration
Source: www.nyvalvesconference.comCategories: General Medicine NewsTweet-
Early-bird pricing for #NYValves2025 ends TONIGHT at 11:59 PM EDT! Register now to secure your spot in the most anticipated structural heart disease meeting of the year: https://t.co/C5FVC4ey4L #interventionalcardiology @crfheart https://t.co/Hy21qKipY2
-
-
Mashup Score: 0Acute Coronary Care in Ethiopia - 13 hour(s) ago
Mamas Mamas talks to Tesfaye Telila about the landscape of acute coronary care in Ethiopa, where just a few dozen cardiologists contend with a population of 120 million people.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Acute Coronary Care in Ethiopia https://t.co/6KMybeU1mK https://t.co/1b9ttnzjwV
-
-
Mashup Score: 11FDA Approves Triple Therapy Polypill for High Blood Pressure - 1 day(s) ago
The combination will be available in several doses and is also approved as a first-line option for patients with hypertension.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
The first triple therapy polypill to treat patients with hypertension has been approved by the @US_FDA. The pill, Widaplik, contains the ARB telmisartan, calcium-channel blocker amlodipine, and diuretic indapamide. Read the latest here: https://t.co/NFC5Oy0gVl https://t.co/JhvmNkmO8D
-
-
Mashup Score: 0
Martin B. Leon, MD Columbia University New York, NY Tsuyoshi Kaneko, MD Washington University St. Louis, MO Brian Lindman, MD Vanderbilt University Nashville, TN Jeffrey Popma, MD Harvard Medical School Cambridge, MA Forgot Your Password? Enter the email you used to register to reset your password.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
DurAVR® THV is a novel biomimetic valve that aims to restore native flow in patients with aortic stenosis. In our latest webcast, a panel of experts provides insight on this new treatment option: https://t.co/novsZ9IwSa https://t.co/BAd1zu0XBB
-
-
Mashup Score: 2Valve Thrombosis in TTVR Not Uncommon: Meta-analysis - 1 day(s) ago
Most cases are subclinical, but given the newness of the therapy, it’s necessary to keep tabs on the issue going forward.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Valve Thrombosis in TTVR Not Uncommon: Meta-analysis https://t.co/9hXdeB9iQv https://t.co/AgbiViQn1f
-
-
Mashup Score: 6Registration - 1 day(s) ago
Registration
Source: www.nyvalvesconference.comCategories: General Medicine NewsTweet-
Early-bird pricing for #NYValves2025 ends TONIGHT at 11:59 PM EDT! Register now to secure your spot in the most anticipated structural heart disease meeting of the year: https://t.co/C5FVC4ey4L #interventionalcardiology @crfheart https://t.co/Hy21qKipY2
-
-
Mashup Score: 1
Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate the safety and efficacy of the MagicTouch Sirolimus-Coated Balloon (SCB) compared to an everolimus-eluting stent (EES) in treating de-novo coronary vessels. TRANSFORM II (Sirolimus-Coated Ballo on Versus Drug-Eluting Stent in Native Coronary Vessels) is an investigator-driven trial sponsored by Fondazione
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels https://t.co/Yl6uDMSR5o https://t.co/CTUAYTdA9e
-
Simple Sitting-Rising Test Linked to Natural and CV Mortality https://t.co/RTc8oiGvrc https://t.co/mSlkyZSffa